Nasdaq:US$15.39 (+0.28) | HKEX:HK$24.42 (+0.22) | AIM:£2.29 (+0.01)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 腫瘤學 / 免疫學 | 2007-06-18

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility